United States · FDA National Drug Code directory
KYMRIAH
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0846_381f1ba3-f115-424f-9890-75eb06ab6666
- Product NDC
- 0078-0846
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- tisagenlecleucel
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20170830
- Source listing expiry
- 20261231
Source-listed ingredients
- TISAGENLECLEUCEL — 2000000 1/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, SUSPENSION in 1 BAG (0078-0846-19) · 0078-0846-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →